Key TakeawaysNew regulatory initiatives in 2026 impacted DE&I, creating challenges and opportunities for the pharmaceutical industry.Companies are urged to integrate DE&I into core operations, focusing on patient engagement, community partnerships, and R&D diversity.A top-down leadership approach enhances diversity by setting a tone of accountability and commitment across the organization.Reducing health disparities involves prioritizing diverse clinical […]
